DCF Advisers’s Kindred Biosciences, Inc. KIN Stock Holding History

DCF Advisers’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-362,315	Closed	-$3.32M	–	104
2021 Q2	$3.32M	Buy	362,315 +161,315	+80%	+$938K	1.18%	22
2021 Q1	$999K	Buy	201,000 +161,000	+403%	+$778K	0.43%	50
2020 Q4	$172K	Buy	+40,000	New	+$163K	0.07%	86

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

DCF Advisers's KIN Position: Q3 2021 in Review

DCF Advisers sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 362,315 shares — an estimated $3.32M sold.

DCF Advisers first reported a position in KIN in Q4 2020 and held it in 3 quarters. The position peaked at $3.32M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

DCF Advisers reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
DCF Advisers sold 362,315 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $3.32M.
DCF Advisers first reported a position in Kindred Biosciences, Inc. in Q4 2020 and held it in 3 quarters.
DCF Advisers's Kindred Biosciences, Inc. position peaked at $3.32M in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on DCF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.